Material Detail

Presents principles underlying preclinical and clinical development of new therapeutic drugs and procedures. Describes and evaluates specific examples, and discusses legal and ethical regulations that apply to drug development.

Course Learning Objectives

• Describe how new drugs and devices are taken from the laboratory to the marketplace in the United States.
• Distinguish Phase I, II, III, and IV studies.
• Evaluate the balance between medical benefit, medical risk, economic reward, and economic risk in the decision making process as it relates to drugs and devices in development.

This will delete the comment from the database. This operation is not reversible. Are you sure you want to do it?

Thank you for reporting a broken "Go to Material" link in MERLOT to help us maintain a collection of valuable learning materials.

If you feel this material is inappropriate for the MERLOT Collection, please click SEND REPORT, and the MERLOT Team will investigate. Thank you!

You are being taken to the material on another site. This will open a new window.

Do not show me this again